Problems obtaining travel insurance for people living with cancer: 4-minute Survey for Cancer patients. Please complete by Friday 22nd September 2023 PLANETS Cancer Charity (alongside Cancer52) would like to invite you to take this survey about your experience as a...
Last year, Neuroendocrine Cancer UK’s Patient Support Co-ordinator, and neuroendocrine cancer patient, Kate, gave a presentation to Ipsen, the manufacturer of Lanreotide, a monthly Somatostatin Analogue prescribed to many members of our patient community. The...
Review of Carcinoid Syndrome: what is is and how it is treated by Joel George et al (Hampshire Hospitals and Kings Healthcare Partners ENETs Centre of Excellence) Online Publication Date: 19 Jun 2023 Neuroendocrine Cancers (aka neuroendocrine neoplasms or NENs) may...
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012 & 2018: A Retrospective, Population-Based Study : published 20th March 2023. A retrospective, population-based study comparing overall survival (OS) between males and females with...
Kate Quirk, Neuroendocrine Cancer UK Patient Support Coordinator, has just been appointed to the INCA Research Committee, after contributing to the completion of a project to bring wider access to Clinical Trials for Neuroendocrine Cancer patients globally. INCA (the...
